Clinical Trial Update: Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines [Phase 4]

View source ↗

Summary

Phase 4 post-marketing safety study of Menactra meningococcal vaccine conducted in healthy children, adolescents, and adults in the Philippines; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-11-14